(Q47257562)

English

Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia

scientific article published in September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

hypercholesterolemia

0 references

1 reference

based on heuristic

inferred from title

Nicoline Hoogerbrugge

1

object named as

Hoogerbrugge N

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

author name string

Jansen H

2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

146

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

1

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

167-174

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

A brief review paper of the efficacy and safety of atorvastatin in early clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: Comparison with selected HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Differences in receptor binding of LDL subfractions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Metabolism of VLDL and LDL subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Large buoyant LDL-like particles in hepatic lipase deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

A dose-response relationship between sex hormone-induced change in hepatic triglyceride lipase and high-density lipoprotein cholesterol in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Genetic control of low-density-lipoprotein subclasses

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Lipoprotein lipase correlates positively and hepatic lipase inversely with calcific atherosclerosis in homozygous familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

On the metabolic function of heparin-releasable liver lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Simvastatin improves chylomicron remnant removal in familial combined hyperlipidemia without changing chylomicron conversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Relations Between Plasma Lipids and Postheparin Plasma Lipases and VLDL and LDL Subfraction Patterns in Normolipemic Men and Women

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Plasma lipoproteins in familial hepatic lipase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900125-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(99)00125-2

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 January 2018

http://europepmc.org/abstract/MED/10487500

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47257562&oldid=2148278770"